Ubiquitous Dopamine Deficit Hypotheses in Cocaine Use Disorder Lack Support: Response to Leyton

Am J Psychiatry. 2021 May 1;178(5):469-470. doi: 10.1176/appi.ajp.2020.20111581r.

Authors

Clifford M Cassidy¹, Anna B Konova¹, Anissa Abi-Dargham¹, Diana Martinez¹, Guillermo Horga¹

Affiliation

¹ University of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).

PMID: 33979543
DOI: 10.1176/appi.ajp.2020.20111581r

No abstract available

Keywords: Addiction Psychiatry; Cocaine Use Disorder; Dopamine; Stimulants; Substance-Related and Addictive Disorders.

Publication types

Letter
Comment

MeSH terms

Central Nervous System Stimulants* / therapeutic use
Cocaine* / therapeutic use
Dopamine
Humans
Substance-Related Disorders* / drug therapy

Substances

Central Nervous System Stimulants
Cocaine
Dopamine

Grants and funding